Phase 1 LITESPARK-001 (MK-6482-001) Study of Belzutifan in Advanced Solid Tumors: Update of the Clear Cell Renal Cell Carcinoma (ccrcc) Cohort with More Than 3 Years of Total Follow-Up.
Journal of Clinical Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined